Hostname: page-component-586b7cd67f-dlnhk Total loading time: 0 Render date: 2024-11-28T14:18:01.240Z Has data issue: false hasContentIssue false
  • English
  • Français

Utility of the cycle threshold in anticipating the next phase of the coronavirus disease 2019 (COVID-19) pandemic

Part of: SARS-CoV-2/COVID-19

Published online by Cambridge University Press:  22 February 2022

Jessica A. Penney Open the ORCID record for Jessica A. Penney [Opens in a new window] ,
Amanda W. Jung ,
Benjamin C. Koethe  and
Shira I. Doron
Jessica A. Penney*
Affiliation:
Division of Geographic Medicine and Infectious Disease, Tufts Medical Center, Boston, Massachusetts
Amanda W. Jung
Affiliation:
Tufts University School of Public Health, Boston, Massachusetts
Benjamin C. Koethe
Affiliation:
Biostatistics, Epidemiology and Research Design Center, Tufts Clinical and Translational Science Institute (CTSI), Boston, Massachusetts
Shira I. Doron*
Affiliation:
Division of Geographic Medicine and Infectious Disease, Tufts Medical Center, Boston, Massachusetts
*
Author for correspondence: Jessica A. Penney, E-mail: [email protected]. Shira I. Doron, E-mail: [email protected]
Author for correspondence: Jessica A. Penney, E-mail: [email protected]. Shira I. Doron, E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Research Brief
Information
Infection Control & Hospital Epidemiology , Volume 43 , Issue 6 , June 2022 , pp. 800 - 801
Check for updates
Copyright
© The Author(s), 2022. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Cheng, MP, Papenburg, J, Desjardins, M, et al. Diagnostic testing for severe acute respiratory syndrome-related coronavirus 2: a narrative review. Ann Intern Med 2020;172:726–734.CrossRefGoogle ScholarPubMed
Tom, MR, Mina, MJ. To interpret the SARS-CoV-2 test, consider the cycle threshold value. Clin Infect Dis 2020;71:2252–2254.CrossRefGoogle ScholarPubMed
Lai, CC, Wang, JH, Hsueh, PR. Population-based seroprevalence surveys of anti–SARS-CoV-2 antibody: an up-to-date review. Int J Infect Dis 2020;101:314–322.CrossRefGoogle ScholarPubMed
Lipsitch, M, Swerdlow, DL, Finelli, L. Defining the epidemiology of COVID-19—studies needed. N Engl J Med 2020;382:1194–1196.CrossRefGoogle ScholarPubMed
Hay, JA, Kennedy-Shaffer, L, Kanjilal, S, et al. Estimating epidemiologic dynamics from cross-sectional viral load distributions. Science 2021;373:eabh0635.CrossRefGoogle Scholar
Calistri, P, Danzetta, ML, Amato, L, et al. Epidemiological significance of SARS-CoV-2 RNA dynamic in naso-pharyngeal swabs. Microorganisms 2021;9:1264.CrossRefGoogle ScholarPubMed
Abbott RealTime SARS-CoV-2 [EUA Package Insert]. Abbott Molecular website. https://www.fda.gov/media/136258/download. Published July 2020. Accessed July 13, 2021.Google Scholar
Degli-Angeli, E, Dragavon, J, Huang, ML, et al. Validation and verification of the Abbott RealTime SARS-CoV-2 assay analytical and clinical performance. J Clin Virol 2020;129:104474.CrossRefGoogle ScholarPubMed
COVID-19 response reporting. Raw data used to create dashboard. Massachusetts Department of Public Health website. https://www.mass.gov/info-details/covid-19-response-reporting. Accessed September 20, 2021.Google Scholar
Tso, CF, Garikipati, A, Green-Saxena, A, Mao, Q, Das, R. Correlation of population SARS-CoV-2 cycle threshold values to local disease dynamics: exploratory observational study. JMIR Public Health Surveill 2021;7:e28265.CrossRefGoogle ScholarPubMed